alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF TEXAS

LUBBOCK DIVISION

JANE G. GARZA, )

)

Plaintiff, )

)

v. )

)

JO ANNE B. BARNHART, )

Commissioner of Social Security, )

) Civil Action No. 5:05-CV-099-C

Defendant. ) ECF

ORDER

Plaintiff is appealing an adverse decision of the Defendant, Jo Anne B. Barnhart,

Commissioner of Social Security, pursuant to 42 U.S.C. § 405(g). The United States Magistrate

Judge filed her Report and Recommendation on December 23, 2005. No written objections have

been filed. It is, therefore,

ORDERED that the findings and conclusions in the Report and Recommendation are

hereby ADOPTED as the findings and conclusions of the Court and that the above-styled and

numbered cause is hereby dismissed with prejudice.

Dated this 9th day of January, 2006.

_________________________________

SAM R. CUMMINGS

UNITED STATES DISTRICT COURT

 

 Case 5:05-cv-00099-C Document 22 Filed 01/09/06 Page 1 of 1 PageID 136
Barris J. HARRELL, Sr., Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-2023

District Court of Appeal of Florida, Second District.

Opinion filed April 24, 2019.

PER CURIAM.

Affirmed.

VILLANTI, KHOUZAM, and BADALAMENTI, JJ., Concur.
```

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 25 Introduced in Senate (IS)]

<DOC>

119th CONGRESS
  1st Session
S. RES. 25

  Condemning the commutation of the death sentence of Marvin Charles 
      Gabrion II granted by President Biden on December 23, 2024.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 14, 2025

 Mr. Cotton submitted the following resolution; which was referred to 
                     the Committee on the Judiciary

_______________________________________________________________________

                               RESOLUTION

 
  Condemning the commutation of the death sentence of Marvin Charles 
      Gabrion II granted by President Biden on December 23, 2024.

    Resolved,

SECTION 1. SENSE OF THE SENATE REGARDING THE COMMUTATION OF THE DEATH 
              SENTENCE OF MARVIN CHARLES GABRION II GRANTED BY 
              PRESIDENT BIDEN ON DECEMBER 23, 2024.

    It is the sense of the Senate that--
            (1) President Joseph R. Biden undermined the rule of law 
        and robbed victims of justice when he commuted the death 
        sentence of Marvin Charles Gabrion II on December 23, 2024;
            (2) Marvin Gabrion was sentenced to death for murdering 19-
        year-old Rachel Timmerman just 2 days before she was scheduled 
        to testify that Gabrion had abducted and raped her;
            (3) Marvin Gabrion was also the prime suspect in the 
        disappearance and murder of several other individuals, 
        including Rachel Timmerman's 11-month-old daughter and 2 
        potential witnesses at his rape trial;
            (4) this commutation is a reprehensible insult to the 
        victims of Marvin Gabrion;
            (5) President Biden claimed that he commuted the death 
        sentences of Marvin Gabrion and 36 other murderers out of a 
        principled opposition to the death penalty but refused to 
        commute the death sentences of the 3 most controversial death 
        row inmates, demonstrating that President Biden was motivated 
        by politics, not principles; and
            (6) the Senate unequivocally condemns this commutation.
                                 <all>
```
EXHIBIT 32

             CERTIFICATION PURSUANT TO 18 U.S.C. SS.1350, AS ADOPTED
           PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the Quarterly Report of Biotel Inc. (the "Company")
on Form 10-QSB for the period ended December 31, 2005 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned, in the capacities listed below, hereby certifies, pursuant to
18U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that: (i) The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and (ii) The information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.


                                               BIOTEL INC.

Date: February 14, 2005                        By: /s/ B. Steven Springrose
                                               ---------------------------------
                                               B. Steven Springrose
                                               Chief Executive Officer
                                               and President
                                               (principal executive officer)


Date: February 14, 2005                        By: /s/ Judy E. Naus
                                               ---------------------------------
                                               Judy E. Naus
                                               Chief Financial Officer
                                               (principal financial officer)




         A signed original of this written statement required by Section 906 has
been provided to Biotel Inc. and will be retained by Biotel Inc. and furnished
to the Securities and Exchange Commission or its staff upon request.

GP:1904472 v1
Case 4:05-cv-00582-A Document 13 Filed 02/08/06 Page 1 of 4 PageID 65
 

 Case 4:05-cv-00582-A Document 13 Filed 02/08/06 Page 2 of 4 PageID 66
 

 Case 4:05-cv-00582-A Document 13 Filed 02/08/06 Page 3 of 4 PageID 67
 

 Case 4:05-cv-00582-A Document 13 Filed 02/08/06 Page 4 of 4 PageID 68
Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE
SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q/A of Language Line, Inc. (the Company) for the quarter
ended March 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Dennis G. Dracup, Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



|(i) | The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended; and
|--- | -----------------------------------------------------------------------------------------------------------------------------------------



|(ii) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Language Line, Inc.
|---- | -----------------------------------------------------------------------------------------------------------------------------------------------------------

Date: September 13, 2007



| |  |                                      |  | 
| |  | ------------------------------------ |  | 
| |  | /s/ Dennis G. Dracup                 |  | 
| |  | Dennis G. Dracup                     |  | 
| |  | Chief Executive Officer and Director |  | 
| |  | (Principal Executive Officer)        |  | 

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350 and is not being
filed as part of this Report.
117TH CONGRESS 

1ST SESSION S. 854 

AN ACT 

To designate methamphetamine as an emerging threat, and 

for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

†S 854 ES

1 SECTION 1. SHORT TITLE. 

2 This Act may be cited as the ‘‘Methamphetamine Re3 sponse Act of 2021’’. 

4 SEC. 2. DECLARATION OF EMERGING THREAT. 

5 (a) IN GENERAL.—Congress declares methamphet6 amine an emerging drug threat, as defined in section 702 

7 of the Office of National Drug Control Policy Reauthor8 ization Act of 1998 (21 U.S.C. 1701), in the United 

9 States. 

10 (b) REQUIRED EMERGING THREAT RESPONSE

11 PLAN.—Not later than 90 days after the date of enact12 ment of this Act, the Director of the Office of National 

13 Drug Control Policy shall establish and implement an 

14 Emerging Threat Response Plan that is specific to meth15 amphetamine in accordance with section 709(d) of the Of16 fice of National Drug Control Policy Reauthorization Act 

17 of 1998 (21 U.S.C. 1708(d)). 

Passed the Senate December 13, 2021. 

Attest: 

Secretary. 

117TH CONGRESS 

1ST SESSION S. 854 

AN ACT 

To designate methamphetamine as an emerging 

threat, and for other purposes.
Case 3:05-cv-00636-R Document 5 Filed 10/18/05 Page 1 of 1 PageID 45
Sherman Fitzgerald TATE v. STATE

CR-16-1065

Court of Criminal Appeals of Alabama.

December 8, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Kyle William HAMRICK v. STATE

CR-16-1073

Court of Criminal Appeals of Alabama.

December 8, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Exhibit 32.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED
PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of MHI Hospitality Corporation (the Corporation) on Form 10-Q for the period ending March 31,
2009 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Andrew M. Sims, Chief Executive Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
| | --- | --------------------------------------------------------------------------------------------------------------------------------------------------------



|                   |  |        |  |                                      
|------------------ |  | ------ |  | -------------------------------------
|Date: May 20, 2009 |  |        |  |                                      
|                   |  |       
|                   |  | By:    |  | /s/ Andrew M. Sims                   
|                   |  | Name:  |  | Andrew M. Sims                       
|                   |  | Title: |  | President and Chief Executive Officer
Angel Luis RIVERA, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D19-0393

District Court of Appeal of Florida, Second District.

May 17, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Appeal is dismissed.
Daniel E. AUGUST v. Darrell VANNOY, et al.

NO. 2018-KH-0213

Supreme Court of Louisiana.

February 11, 2019

WRIT NOT CONSIDERED. Petitioner has not demonstrated that he sought review in the court of appeal before filing in this Court nor shown the "extraordinary circumstances" that would justify bypassing that level of review. La.S.Ct.R. X § 5(b).
Statement

Jill Long Thompson, Board Chair 

Farm Credit Administration Board Meeting

May 8, 2014

I am very proud of the work of FCA staff, and also the commitment of my fellow Board 

Members, that have led to this Proposed Capital Rule we are considering today. Growing up on 

a family farm, I remember learning at an early age the importance of having “at least two ways 

to pay for something.” It was much later as a business student in college that I began to 

understand the meaning and importance of capital.

Capital is important to both lenders and borrowers. In a cooperative network of borrower-owned 

lending institutions, the capital structure necessary to achieve safety and soundness has its own 

unique characteristics. 

We have revised our capital regulations over time to reflect changing statutes, business 

conditions, and widely accepted conventions. These proposed regulations are designed to 

improve the quality of System capital and to make our capital regulations comparable with those 

of the regulators of other financial institutions. We have adapted the Basel III framework to the 

System’s unique characteristics, its cooperative structure and GSE mission. Cooperative 

principles require current borrowers to provide the capital for the safe operation of the System. 

This proposed rule adapts the Basel III framework for use with the System. We invite comments 

on all aspects of our proposal, but particularly on those adaptations we have made to 

accommodate the unique features of the System.
Davarius Antawn DURHAM, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D18-4806

District Court of Appeal of Florida, Second District.

April 22, 2019

**FLORIDA DECISION WITHOUT PUBLISHED OPINION**

Dismissed.
C OURT OF A PPEALS FOR THE F IRST D ISTRICT OF T EXAS AT H OUSTON

O RDER

Appellate case name: Dennis Gallien v. The State of Texas

Appellate case number: 01

- 22

- 00398

- CR

Trial court case number: 1541083

Trial court: 339th District Court of Harris County

Counsel for appellant has filed a motion to transfer volume 5 of the reporter’s record filed in 01

- 19

- 00882

- CR to this case. Both case number 01

- 19

- 00882

- CR and this case share the same parties and arise from the same trial court case. We held t his motion for a response but none was filed.

We grant the motion and direct the Clerk of this Court to transfer a copy of Volume 5 of the reporter’s record in case number 01

- 19

- 00882

- CR to this case.

It is so ORDERED.

Judge’s signature:

____

/s/ Richard Hightower

______  Acting individually  Acting for the Court

Date: ___ October 6, 2022

____
UN PUBLISHED
UNITED STATES COURT OF APPEALS FOR THE FOURTH CIRCUIT

No. 19
- 6240

ROBERT EARL SMITH , Petitioner

- Appellant ,

v. SUPERINTENDANT HACKWORTH , Respondent

- Appellee

.

Appeal from the United States District Court for the Eastern District of Virginia , at Alexandria

. Claude M. Hilton, Senior District Judge. ( 1:18

- cv - 01449

- CMH

- JFA )

Submitted : June 20, 2019 Decided: July 3, 2019

Before GREGORY, Chief Judge, RICHARDSON , Circuit Judge , and SHEDD, Senior Circuit Judge.

Dismissed by un published per curiam opinion

. Robert Earl Smith, Appellant Pro Se.
Unpublished opinions are not binding precedent in this circuit.2 PER CURIAM: Robert Earl Smith seeks to appeal the district court’s order dismissing his 28 U.S.C. § 2254 (2012) petition without prejudice . The order is not appealable unless a circuit justice or judge issues a certificate of appealability. 28 U.S.C. § 2253(c)(1)(A) (2012). A certificate of appealability will not issue absent “a substantial showing of the denial of a constitutional right.” 28 U.S.C. § 2253(c)(2) (2012). When the district court denies relief on the merits, a prisoner satisfies this standard by demonstrating that reasonable j urists would find that the district court’s assessment of the constitutional claims is debatable or wrong. Slack v. McDaniel , 529 U.S. 473, 484 (2000); see Miller

- El v. Cockrell , 537 U.S. 322, 336

- 38 (2003). When the district court denies relief
on proce dural grounds, the prisoner must demonstrate both that the dispositive procedural ruling is debatable, and that the petition states a debatable claim of the denial of a constitutional right. Slack , 529 U.S. at 484

- 85. We have independently reviewed the record and conclude that Smith has not made the requisite showing. Specifically, Smith’s failure to challenge in his informal brief the district court’s finding that he has not yet exhausted his state court remedies forecloses our consideration of that di spostitive ruling. See 4th Cir. R. 34(b); see also Jackson v. Lightsey , 775 F.3d 170, 177 (4th Cir. 2014) ( “The informal brief is an important document; under Fourth Circuit rules, our review is limited to issues preserved in that brief.”). A ccordingly, we deny a certificate of appealability, deny leave to proceed in forma pauperis, and dismiss the appeal. We dispense with oral argument because the3 facts and legal contentions are adequately presented in the materials before this court and
arg ument would not aid the decisional process.
DISMISSED
```

[Federal Register Volume 90, Number 12 (Tuesday, January 21, 2025)]
[Notices]
[Pages 7149-7150]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2025-01330]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The contract proposals and grant applications the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the contract proposals, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; Phase 1 Clinical Trial Contract 
Review.
    Date: February 10, 2025.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Address: National Institutes of Health, Neuroscience Center, 
6001 Executive Boulevard, Rockville, MD 20852.
    Meeting Format: Virtual Meeting.
    Contact Person: Joel A Saydoff, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard, 
Rockville, MD 20852, 301-496-9223 [email protected].

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Initial Review Group Neurological Sciences and Disorders 
A Study Section NSD-A Review Meeting.
    Date: February 13-14, 2025.
    Time: 9:00 a.m. to 3:00 p.m.

[[Page 7150]]

    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Neuroscience Center, 
6001 Executive Boulevard, Rockville, MD 20852.
    Meeting Format: Virtual Meeting.
    Contact Person: Natalia Strunnikova, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural 
Activities, NINDS/NIH/DHHS, NSC, 6001 Executive Boulevard, 
Rockville, MD 20852, 301-402-0288 [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: January 14, 2025.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2025-01330 Filed 1-17-25; 8:45 am]
BILLING CODE 4140-01-P
```
Exhibit 99.2

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, Michael S. Thomsen, Chief Financial Officer of Scheid Vineyards, Inc. (the "Registrant"), do hereby certify in accordance with 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, based on my knowledge:



A
signed original of this written statement required by Section 906 has been provided to the Registrant and will be retained by the Registrant and furnished to the Securities and
Exchange Commission or its staff upon request.

|Dated: March 28, 2003 |  | /s/MICHAEL S. THOMSENMichael S. Thomsen
Chief Financial Officer
|--------------------- |  | ---------------------------------------------------------------

---

QuickLinks
Gregory S. FRIEDLANDER, as Personal Representative of the Estate of Burton Glen Friedlander, et al., Appellant, v. Steven FRIEDLANDER, Appellee.

No. 4D18-2516

District Court of Appeal of Florida, Fourth District.

[April 18, 2019]

**DECISION WITHOUT PUBLISHED OPINION**

*Affirmed.*
CERTIFICATIONS I, Desmond Ross , the Chief Executive Officer and Chief Financial Officer of  , Quantum Solar Power Corp..(the Registrant), certify that; (1)I have reviewed this Quarterly Report on Form 10-Q of the Registrant;(2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;(3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;(4)I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934) for the Registrant and have:a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the Registrant is made known to me by others within those entities, particularly during the period in which this report is being prepared;b)Evaluated the effectiveness of the Registrants disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; andc)Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and(5)I have disclosed, based on my most recent evaluation of the internal control over financial reporting, to the Registrants auditors and the audit committee of Registrants board of directors (or persons performing the equivalent functions):a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrants ability to record, process, summarize and report financial information; andb)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrants internal control over financial reporting.  Date:February 13, 2009/s/ Desmond RossBy:Desmond RossTitle:Chief Executive Officerand Chief Financial Officer
EX PARTE Barry Lemorris COSBY

CR-16-0807

Court of Criminal Appeals of Alabama.

October 26, 2017

**DECISION WITHOUT PUBLISHED OPINION**

Reh. denied.
<PAGE>

                                                                    Exhibit 23.1

                       CONSENT OF INDEPENDENT ACCOUNTANTS

We hereby consent to the inclusion of our Independent Auditor's Report dated
March 8, 2001 regarding the consolidated balance sheets of BYL Bancorp and
Subsidiary as of December 31, 2000 and 1999, and the related consolidated
statements of income, changes in stockholders' equity, and cash flows for each
of the three years in the period ended December 31, 2000 in the Form 10-K filed
with the Securities and Exchange Commission.

                  VAVRINEK, TRINE, DAY & CO., LLP

March 25, 2001
Laguna Hills, California
Joshua Frank MILLER v. Reinah Charlene MILLER

2160529

Court of Civil Appeals of Alabama.

October 27, 2017

Affirmed.